Do analysts recommend TRON or NAKA?

KindlyMD has a consensus price target of $20.00, suggesting a potential upside of 133.10%. Given KindlyMD's stronger consensus rating and higher probable upside, analysts clearly believe KindlyMD is more favorable than Tron. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Tron 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 KindlyMD 1 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.40

Which has stronger valuation and earnings, TRON or NAKA?

Tron has higher revenue and earnings than KindlyMD. Tron is trading at a lower price-to-earnings ratio than KindlyMD, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Tron $4.74M 122.10 -$16.81M -$0.11 N/A KindlyMD $1.82M 84.39 -$52.23M -$35.85 N/A

Is TRON or NAKA more profitable?

Tron has a net margin of 135.58% compared to KindlyMD's net margin of -1,067.93%. Tron's return on equity of -5.60% beat KindlyMD's return on equity. Company Net Margins Return on Equity Return on Assets Tron 135.58% -5.60% -5.53% KindlyMD -1,067.93% -63.45% -41.04%

Do analysts rate NAKA or CEPO?

KindlyMD currently has a consensus price target of $20.00, suggesting a potential upside of 133.10%. Given KindlyMD's stronger consensus rating and higher possible upside, equities analysts clearly believe KindlyMD is more favorable than Cantor Equity Partners. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score KindlyMD 1 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.40 Cantor Equity Partners 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts rate NAKA or TROO?

KindlyMD presently has a consensus target price of $20.00, suggesting a potential upside of 133.10%. Given KindlyMD's stronger consensus rating and higher probable upside, equities research analysts plainly believe KindlyMD is more favorable than TROOPS. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score KindlyMD 1 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.40 TROOPS 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has stronger valuation & earnings, NAKA or TROO?

TROOPS has higher revenue and earnings than KindlyMD. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio KindlyMD $1.82M 84.39 -$52.23M -$35.85 N/A TROOPS $17.10M 11.93 -$27.91M N/A N/A

Is NAKA or TROO more profitable?

TROOPS has a net margin of 0.00% compared to KindlyMD's net margin of -1,067.93%. TROOPS's return on equity of 0.00% beat KindlyMD's return on equity. Company Net Margins Return on Equity Return on Assets KindlyMD -1,067.93% -63.45% -41.04% TROOPS N/A N/A N/A

KindlyMD (NAKA) Competitors

$8.58 +0.32 (+3.87%)

As of 10/13/2026 04:00 PM Eastern

Compare

NAKA vs. TRON, FWDI, ACTG, CEPO, and TROO

Should you buy KindlyMD stock or one of its competitors? KindlyMD's main competitors and comparable companies include Tron (TRON), Forward Industries (FWDI), Acacia Research (ACTG), Cantor Equity Partners (CEPO), and TROOPS (TROO). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "multi-sector holdings" industry.

How does KindlyMD compare to Tron?

Tron (NASDAQ:TRON) and KindlyMD (NASDAQ:NAKA) are both small-cap finance companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, dividends, institutional ownership, risk, profitability, valuation and media sentiment.

Tron has higher revenue and earnings than KindlyMD. Tron is trading at a lower price-to-earnings ratio than KindlyMD, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tron	$4.74M	122.10	-$16.81M	-$0.11	N/A
KindlyMD	$1.82M	84.39	-$52.23M	-$35.85	N/A

Tron has a beta of 8.69, indicating that its stock price is 769% more volatile than the broader market. Comparatively, KindlyMD has a beta of 15.82, indicating that its stock price is 1,482% more volatile than the broader market.

KindlyMD has a consensus price target of $20.00, suggesting a potential upside of 133.10%. Given KindlyMD's stronger consensus rating and higher probable upside, analysts clearly believe KindlyMD is more favorable than Tron.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tron	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
KindlyMD	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

In the previous week, Tron had 7 more articles in the media than KindlyMD. MarketBeat recorded 8 mentions for Tron and 1 mentions for KindlyMD. KindlyMD's average media sentiment score of 1.79 beat Tron's score of 0.35 indicating that KindlyMD is being referred to more favorably in the news media.

Company	Overall Sentiment
Tron	Neutral
KindlyMD	Very Positive

28.0% of Tron shares are owned by institutional investors. 86.2% of Tron shares are owned by company insiders. Comparatively, 24.5% of KindlyMD shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Tron has a net margin of 135.58% compared to KindlyMD's net margin of -1,067.93%. Tron's return on equity of -5.60% beat KindlyMD's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Tron	135.58%	-5.60%	-5.53%
KindlyMD	-1,067.93%	-63.45%	-41.04%

Summary

Tron beats KindlyMD on 10 of the 15 factors compared between the two stocks.

How does KindlyMD compare to Forward Industries?

Forward Industries (NASDAQ:FWDI) and KindlyMD (NASDAQ:NAKA) are both small-cap finance companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, earnings, profitability, analyst recommendations, risk, media sentiment, institutional ownership and valuation.

In the previous week, Forward Industries had 5 more articles in the media than KindlyMD. MarketBeat recorded 6 mentions for Forward Industries and 1 mentions for KindlyMD. KindlyMD's average media sentiment score of 1.79 beat Forward Industries' score of -0.11 indicating that KindlyMD is being referred to more favorably in the news media.

Company	Overall Sentiment
Forward Industries	Neutral
KindlyMD	Very Positive

Forward Industries presently has a consensus target price of $13.50, indicating a potential upside of 87.76%. KindlyMD has a consensus target price of $20.00, indicating a potential upside of 133.10%. Given KindlyMD's stronger consensus rating and higher possible upside, analysts plainly believe KindlyMD is more favorable than Forward Industries.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Forward Industries	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
KindlyMD	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

Forward Industries has a beta of 0.84, suggesting that its share price is 16% less volatile than the broader market. Comparatively, KindlyMD has a beta of 15.82, suggesting that its share price is 1,482% more volatile than the broader market.

KindlyMD has a net margin of -1,067.93% compared to Forward Industries' net margin of -2,073.82%. Forward Industries' return on equity of -18.05% beat KindlyMD's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Forward Industries	-2,073.82%	-18.05%	-17.03%
KindlyMD	-1,067.93%	-63.45%	-41.04%

KindlyMD has lower revenue, but higher earnings than Forward Industries. KindlyMD is trading at a lower price-to-earnings ratio than Forward Industries, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Forward Industries	$18.19M	29.19	-$166.97M	$0.12	59.92
KindlyMD	$1.82M	84.39	-$52.23M	-$35.85	N/A

Summary

KindlyMD beats Forward Industries on 8 of the 13 factors compared between the two stocks.

How does KindlyMD compare to Acacia Research?

Acacia Research (NASDAQ:ACTG) and KindlyMD (NASDAQ:NAKA) are both small-cap finance companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, media sentiment, valuation, earnings, institutional ownership, analyst recommendations, risk and profitability.

Acacia Research has a net margin of -5.39% compared to KindlyMD's net margin of -1,067.93%. Acacia Research's return on equity of 0.44% beat KindlyMD's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Acacia Research	-5.39%	0.44%	0.33%
KindlyMD	-1,067.93%	-63.45%	-41.04%

Acacia Research has a beta of 0.51, meaning that its share price is 49% less volatile than the broader market. Comparatively, KindlyMD has a beta of 15.82, meaning that its share price is 1,482% more volatile than the broader market.

Acacia Research currently has a consensus price target of $6.00, indicating a potential upside of 36.36%. KindlyMD has a consensus price target of $20.00, indicating a potential upside of 133.10%. Given KindlyMD's stronger consensus rating and higher probable upside, analysts clearly believe KindlyMD is more favorable than Acacia Research.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Acacia Research	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
KindlyMD	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

In the previous week, Acacia Research had 1 more articles in the media than KindlyMD. MarketBeat recorded 2 mentions for Acacia Research and 1 mentions for KindlyMD. KindlyMD's average media sentiment score of 1.79 beat Acacia Research's score of 0.61 indicating that KindlyMD is being referred to more favorably in the news media.

Company	Overall Sentiment
Acacia Research	Positive
KindlyMD	Very Positive

86.7% of Acacia Research shares are owned by institutional investors. 1.7% of Acacia Research shares are owned by company insiders. Comparatively, 24.5% of KindlyMD shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Acacia Research has higher revenue and earnings than KindlyMD. Acacia Research is trading at a lower price-to-earnings ratio than KindlyMD, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Acacia Research	$285.23M	1.51	$21.68M	-$0.15	N/A
KindlyMD	$1.82M	84.39	-$52.23M	-$35.85	N/A

Summary

Acacia Research beats KindlyMD on 8 of the 15 factors compared between the two stocks.

How does KindlyMD compare to Cantor Equity Partners?

KindlyMD (NASDAQ:NAKA) and Cantor Equity Partners (NASDAQ:CEPO) are both small-cap finance companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, media sentiment, profitability, valuation, earnings, risk and dividends.

KindlyMD currently has a consensus price target of $20.00, suggesting a potential upside of 133.10%. Given KindlyMD's stronger consensus rating and higher possible upside, equities analysts clearly believe KindlyMD is more favorable than Cantor Equity Partners.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
KindlyMD	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Cantor Equity Partners	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Cantor Equity Partners has lower revenue, but higher earnings than KindlyMD. Cantor Equity Partners is trading at a lower price-to-earnings ratio than KindlyMD, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
KindlyMD	$1.82M	84.39	-$52.23M	-$35.85	N/A
Cantor Equity Partners	N/A	N/A	-$6.66M	-$0.29	N/A

Cantor Equity Partners has a net margin of 0.00% compared to KindlyMD's net margin of -1,067.93%. Cantor Equity Partners' return on equity of 0.00% beat KindlyMD's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
KindlyMD	-1,067.93%	-63.45%	-41.04%
Cantor Equity Partners	N/A	N/A	-0.74%

KindlyMD has a beta of 15.82, indicating that its stock price is 1,482% more volatile than the broader market. Comparatively, Cantor Equity Partners has a beta of -0.04, indicating that its stock price is 104% less volatile than the broader market.

In the previous week, Cantor Equity Partners had 2 more articles in the media than KindlyMD. MarketBeat recorded 3 mentions for Cantor Equity Partners and 1 mentions for KindlyMD. KindlyMD's average media sentiment score of 1.79 beat Cantor Equity Partners' score of 0.83 indicating that KindlyMD is being referred to more favorably in the media.

Company	Overall Sentiment
KindlyMD	Very Positive
Cantor Equity Partners	Positive

Summary

KindlyMD and Cantor Equity Partners tied by winning 6 of the 12 factors compared between the two stocks.

How does KindlyMD compare to TROOPS?

KindlyMD (NASDAQ:NAKA) and TROOPS (NASDAQ:TROO) are both small-cap finance companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, profitability, risk, dividends, earnings, media sentiment and valuation.

TROOPS has higher revenue and earnings than KindlyMD.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
KindlyMD	$1.82M	84.39	-$52.23M	-$35.85	N/A
TROOPS	$17.10M	11.93	-$27.91M	N/A	N/A

KindlyMD has a beta of 15.82, suggesting that its share price is 1,482% more volatile than the broader market. Comparatively, TROOPS has a beta of 3.51, suggesting that its share price is 251% more volatile than the broader market.

KindlyMD presently has a consensus target price of $20.00, suggesting a potential upside of 133.10%. Given KindlyMD's stronger consensus rating and higher probable upside, equities research analysts plainly believe KindlyMD is more favorable than TROOPS.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
KindlyMD	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
TROOPS	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

TROOPS has a net margin of 0.00% compared to KindlyMD's net margin of -1,067.93%. TROOPS's return on equity of 0.00% beat KindlyMD's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
KindlyMD	-1,067.93%	-63.45%	-41.04%
TROOPS	N/A	N/A	N/A

In the previous week, TROOPS had 17 more articles in the media than KindlyMD. MarketBeat recorded 18 mentions for TROOPS and 1 mentions for KindlyMD. KindlyMD's average media sentiment score of 1.79 beat TROOPS's score of -0.46 indicating that KindlyMD is being referred to more favorably in the media.

Company	Overall Sentiment
KindlyMD	Very Positive
TROOPS	Neutral

Summary

KindlyMD and TROOPS tied by winning 6 of the 12 factors compared between the two stocks.

Get KindlyMD News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NAKA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

NAKA vs. The Competition

Export

Metric	KindlyMD	Financial Services Industry	Finance Sector	NASDAQ Exchange
Market Cap	$147.81M	$27.89B	$13.51B	$13.21B
Dividend Yield	N/A	6.95%	6.08%	22.89%
P/E Ratio	N/A	14.64	23.01	19.81
Price / Sales	84.39	333.54	489.14	81.34
Price / Cash	N/A	233.06	44.19	53.04
Price / Book	0.18	3.27	2.70	6.03
Net Income	-$52.23M	$1.11B	$1.32B	$380.34M
7 Day Performance	-8.14%	-0.82%	-0.17%	-2.34%
1 Month Performance	4.51%	-0.52%	-2.57%	-5.31%
1 Year Performance	-72.84%	-0.10%	10.16%	-2.94%

KindlyMD Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
NAKA KindlyMD	3.512 of 5 stars	$8.58 +3.9%	$20.00 +133.1%	-75.0%	$147.81M	$1.82M	N/A	N/A	Positive News
TRON Tron	0.0759 of 5 stars	$1.28 -0.8%	N/A	-70.5%	$607.21M	$5.06M	N/A	7
FWDI Forward Industries	3.2924 of 5 stars	$7.39 -9.2%	$13.50 +82.7%	N/A	$545.75M	$18.19M	61.58	60	Gap Down High Trading Volume
ACTG Acacia Research	2.8374 of 5 stars	$4.36 -0.2%	$6.00 +37.6%	+29.0%	$425.48M	$278.37M	N/A	986
CEPO Cantor Equity Partners	N/A	$10.77 +0.2%	N/A	+2.4%	$274.64M	N/A	N/A	2

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:NAKA) was last updated on 10/14/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

KindlyMD (NAKA) Competitors

NAKA vs. TRON, FWDI, ACTG, CEPO, and TROO

How does KindlyMD compare to Tron?

Summary

How does KindlyMD compare to Forward Industries?

Summary

How does KindlyMD compare to Acacia Research?

Summary

How does KindlyMD compare to Cantor Equity Partners?

Summary

How does KindlyMD compare to TROOPS?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

NAKA vs. The Competition

KindlyMD Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

KindlyMD (NAKA) Competitors

NAKA vs. TRON, FWDI, ACTG, CEPO, and TROO

How does KindlyMD compare to Tron?

Which has stronger valuation and earnings, TRON or NAKA?

Which has more risk and volatility, TRON or NAKA?

Do analysts recommend TRON or NAKA?

Does the media refer more to TRON or NAKA?

Do institutionals and insiders have more ownership in TRON or NAKA?

Is TRON or NAKA more profitable?

Summary

How does KindlyMD compare to Forward Industries?

Does the media favor FWDI or NAKA?

Do analysts recommend FWDI or NAKA?

Which has more risk and volatility, FWDI or NAKA?

Is FWDI or NAKA more profitable?

Which has stronger valuation & earnings, FWDI or NAKA?

Summary

How does KindlyMD compare to Acacia Research?

Is ACTG or NAKA more profitable?

Which has more volatility & risk, ACTG or NAKA?

Do analysts rate ACTG or NAKA?

Does the media prefer ACTG or NAKA?

Do insiders & institutionals believe in ACTG or NAKA?

Which has higher valuation & earnings, ACTG or NAKA?

Summary

How does KindlyMD compare to Cantor Equity Partners?

Do analysts rate NAKA or CEPO?

Which has preferable earnings & valuation, NAKA or CEPO?

Is NAKA or CEPO more profitable?

Which has more risk & volatility, NAKA or CEPO?

Does the media prefer NAKA or CEPO?

Summary

How does KindlyMD compare to TROOPS?

Which has stronger valuation & earnings, NAKA or TROO?

Which has more risk and volatility, NAKA or TROO?

Do analysts rate NAKA or TROO?

Is NAKA or TROO more profitable?

Does the media favor NAKA or TROO?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

NAKA vs. The Competition

KindlyMD Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools